Trials / Completed
CompletedNCT00051181
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate that the intraocular pressure(IOP)-lowering efficacy of Travoprost (0.004%) is equal or better than that of Latanoprost 0.005% in patients with chronic angle-closure glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travoprost (0.004%) | |
| DRUG | Latanoprost (0.005%) |
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2003-06-01
- Completion
- 2003-06-01
- First posted
- 2003-01-07
- Last updated
- 2008-08-05
Locations
2 sites across 2 countries: United States, Australia
Source: ClinicalTrials.gov record NCT00051181. Inclusion in this directory is not an endorsement.